| pubmed-article:21205113 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C0016745 | lld:lifeskim |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C0017725 | lld:lifeskim |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:21205113 | lifeskim:mentions | umls-concept:C0376335 | lld:lifeskim |
| pubmed-article:21205113 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:21205113 | pubmed:dateCreated | 2011-1-24 | lld:pubmed |
| pubmed-article:21205113 | pubmed:abstractText | In animals, intracerebroventricular glucose and fructose have opposing effects on appetite and weight regulation. In humans, functional brain magnetic resonance imaging (fMRI) studies during glucose ingestion or infusion have demonstrated suppression of hypothalamic signalling, but no studies have compared the effects of glucose and fructose. We therefore sought to determine if the brain response differed to glucose vs. fructose in humans independently of the ingestive process. | lld:pubmed |
| pubmed-article:21205113 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21205113 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21205113 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21205113 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21205113 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21205113 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21205113 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21205113 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21205113 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21205113 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:21205113 | pubmed:issn | 1463-1326 | lld:pubmed |
| pubmed-article:21205113 | pubmed:author | pubmed-author:KriskoII | lld:pubmed |
| pubmed-article:21205113 | pubmed:author | pubmed-author:HavelP JPJ | lld:pubmed |
| pubmed-article:21205113 | pubmed:author | pubmed-author:AdamsS HSH | lld:pubmed |
| pubmed-article:21205113 | pubmed:author | pubmed-author:RooneyW DWD | lld:pubmed |
| pubmed-article:21205113 | pubmed:author | pubmed-author:StevensA AAA | lld:pubmed |
| pubmed-article:21205113 | pubmed:author | pubmed-author:PurnellJ QJQ | lld:pubmed |
| pubmed-article:21205113 | pubmed:author | pubmed-author:KlopfensteinB... | lld:pubmed |
| pubmed-article:21205113 | pubmed:author | pubmed-author:DunnT NTN | lld:pubmed |
| pubmed-article:21205113 | pubmed:copyrightInfo | © 2011 Blackwell Publishing Ltd. | lld:pubmed |
| pubmed-article:21205113 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21205113 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:21205113 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21205113 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21205113 | pubmed:pagination | 229-34 | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:meshHeading | pubmed-meshheading:21205113... | lld:pubmed |
| pubmed-article:21205113 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21205113 | pubmed:articleTitle | Brain functional magnetic resonance imaging response to glucose and fructose infusions in humans. | lld:pubmed |
| pubmed-article:21205113 | pubmed:affiliation | Department of Medicine, Oregon Health & Science University, Portland, OR, USA. purnellj@ohsu.edu | lld:pubmed |
| pubmed-article:21205113 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21205113 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:21205113 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21205113 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21205113 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
